MannKind Corporation

391 articles about MannKind Corporation

• MannKind Corporation Announces Exercise In Full Of Common Stock Offering Over-Allotment Option

  12/18/2006

• MannKind Corporation Announces Completion Of Concurrent Public Offerings Of Common Stock And Senior Convertible Notes

  12/12/2006

• MannKind Corporation Announces Pricing Of Concurrent Public Offerings Of Common Stock And Senior Convertible Notes

  12/7/2006

• MannKind Corporation Announces Proposed Concurrent Public Offerings Of Common Stock And Senior Convertible Notes

  11/28/2006

• MannKind Corporation Announces Clearance Of IND For MKC1106-PP Immunotherapy In Solid Malignancies

  11/27/2006

• MannKind Corporation Announces Third Quarter Results Release Date, Conference Call And Upcoming Events

  10/26/2006

• The Day In Review: Schering-Plough Corporation Gets Approval For Noxafil

  9/18/2006

• MannKind Corporation Release: Type 2 Diabetes Patients On Technosphere Insulin Exhibited No Adverse Effect On Pulmonary Function With Significant HbA1c Reductions, And Showed Significant Weight Reduction Compared To Injected Insulin Analog

  9/18/2006

• The Day In Review: Biogen Idec, Inc. (Massachusetts) In-Licenses PAH Drug

  9/14/2006

• MannKind Corporation To Present At Upcoming Conferences

  9/14/2006

• MannKind Corporation Reports Second Quarter Financial Results

  8/3/2006

• MannKind Corporation To Hold Second Quarter Financial Results Conference Call On August 3, 2006

  7/27/2006

• MannKind Corporation To Present At Upcoming Conferences

  6/13/2006

• MannKind Corporation To Present At Pacific Growth Equities 2006 Life Sciences Growth Conference

  6/8/2006

• MannKind Corporation Reports First Quarter Financial Results

  5/5/2006

• MannKind Corporation To Hold First Quarter Financial Results Conference Call On May 5, 2006

  4/28/2006

• MannKind Corporation Release: Type 1 Diabetes Patients On Technosphere Insulin Showed HbA1c Improvements, Low Post-Prandial Glucose Fluctuations, And Weight Loss

  4/19/2006

• MannKind Corporation To Present At UBS Global Specialty Pharmaceutical Conference

  4/17/2006

• MannKind Corporation To Webcast Investor Day Presentations

  4/5/2006

• MannKind Corporation To Present At CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference

  3/27/2006